The Institute of Liver and Biliary Sciences is a mono-superspeciality hospital for liver and biliary diseases located at New Delhi, India.

During the past decade, Institute of Liver and Biliary Sciences conducted 154 clinical trials. In the 10-year time frame, 154 clinical trials started and 6 clinical trials were completed, i.e. on average, 3.9% percent of trials that started reached the finish line to date. In the past 5 years, 85 clinical trials started and 3 clinical trials were completed. i.e. 3.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Liver and Biliary Sciences" #1 sponsor was "Institute of Liver and Biliary Sciences, India" with 177 trials, followed by "Gilead Sciences" with 6 trials sponsored, "Azienda Ospedaliera di Padova" with 1 trials sponsored, "Center Trials & Treatment" with 1 trials sponsored and "Hepatopancreatobiliary Surgery Institute of Gansu Province" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Liver and Biliary Sciences" #1 collaborator was "Ehime University Graduate School of Medicine" with 1 trials as a collaborator, "Hyogo Medical University" with 1 trials as a collaborator, "Institute of Liver and Biliary Sciences (ILBS)" with 1 trials as a collaborator, "Korea University" with 1 trials as a collaborator and "LanZhou University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Liver and Biliary Sciences" are "Liver Cirrhosis" (23 trials), "Cirrhosis" (14 trials), "Acute-On-Chronic Liver Failure" (10 trials), "Acute on Chronic Liver Failure" (9 trials) and "Chronic Liver Disease" (9 trials). Many other conditions were trialed in "Institute of Liver and Biliary Sciences" in a lesser frequency.

Most popular intervention types in "Institute of Liver and Biliary Sciences" are "Drug" (107 trials), "Other" (69 trials), "Biological" (23 trials), "Procedure" (19 trials) and "Dietary Supplement" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Standard Medical Treatment" (19 trials), "Albumin" (11 trials), "No intervention" (8 trials) and "Carvedilol" (7 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Liver and Biliary Sciences" are 186 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Liver and Biliary Sciences". 9 are not yet recruiting, 27 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 85 completed trials in Institute of Liver and Biliary Sciences, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Liver and Biliary Sciences, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 134 trials that are defined as “Not Applicable".